HC Wainwright & Co. Maintains Buy on Century Therapeutics, Raises Price Target to $5

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Century Therapeutics (NASDAQ:IPSC) with a Buy and raises the price target from $2 to $5.